Is a serum creatinine of 1.29 mg/dL indicative of acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A creatinine of 1.29 mg/dL alone cannot determine if AKI is present—you must compare it to a baseline value.

AKI is diagnosed by the change in creatinine, not by an absolute value. According to KDIGO criteria, AKI requires either a rise of ≥0.3 mg/dL within 48 hours OR a ≥50% increase from baseline within 7 days 1.

How to Determine if This is AKI

You need to answer these questions algorithmically:

Step 1: Identify the Baseline Creatinine

  • Obtain the most recent creatinine from 7-365 days prior when the patient was medically stable 2, 3
  • If unavailable, use the lowest value from the past year (though this may overdiagnose AKI) 2
  • Critical pitfall: Using creatinine during an acute illness as "baseline" will miss many cases of AKI 3

Step 2: Calculate the Change

Compare 1.29 mg/dL to baseline:

  • Absolute change: Is there a rise of ≥0.3 mg/dL within 48 hours? 1

    • Example: If baseline was 1.0 mg/dL, then 1.29 represents a 0.29 mg/dL rise—not quite AKI by absolute criteria
    • If baseline was 0.9 mg/dL, then 1.29 represents a 0.39 mg/dL rise—this IS Stage 1 AKI
  • Percentage change: Is there a ≥50% rise from baseline within 7 days? 1

    • Example: If baseline was 0.8 mg/dL, then 1.29 represents a 61% increase—this IS Stage 1 AKI
    • If baseline was 1.0 mg/dL, then 1.29 represents only a 29% increase—not AKI by percentage criteria

Step 3: Check Urine Output

Even if creatinine criteria aren't met, urine output <0.5 mL/kg/h for >6 hours defines Stage 1 AKI 1

Clinical Significance

Even small creatinine increases below the 0.3 mg/dL threshold are associated with increased mortality 1, 4. Research shows that increases as small as >4 μmol/L (~0.05 mg/dL) from pre-admission values predict worse outcomes 5. However, the formal diagnosis of AKI still requires meeting KDIGO criteria.

Common Pitfalls to Avoid

  1. Don't assume 1.29 mg/dL is "normal"—it may represent significant kidney injury if baseline was lower 4
  2. Don't use admission creatinine as baseline if the patient was already acutely ill 3
  3. Don't ignore rapid reversibility—even if creatinine returns to normal within 48 hours, the AKI episode still carries a 14% mortality risk 4
  4. Don't rely solely on percentage changes in patients with preexisting kidney disease—absolute changes may be more reliable 6, 7

The Bottom Line

Without knowing the baseline creatinine and timing, you cannot diagnose AKI. A creatinine of 1.29 mg/dL could represent:

  • Normal kidney function (if baseline is similar)
  • Stage 1 AKI (if baseline was ≤0.99 mg/dL within 48 hours, or ≤0.86 mg/dL within 7 days)
  • Stage 2 or 3 AKI (if baseline was even lower)

Obtain the baseline creatinine immediately and apply KDIGO criteria to make the diagnosis 1.

References

Research

Rapid reversal of acute kidney injury and hospital outcomes: a retrospective cohort study.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009

Research

The effect of admission and pre-admission serum creatinine as baseline to assess incidence and outcomes of acute kidney injury in acute medical admissions.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2021

Research

Creatinine kinetics and the definition of acute kidney injury.

Journal of the American Society of Nephrology : JASN, 2009

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.